Identification of Endothelial Proteins in Plasma Associated With Cardiovascular Risk Factors
Author(s) -
María Jesús Iglesias,
Larissa D. Kruse,
Laura SánchezRivera,
Linnea Enge,
Philip Dusart,
MunGwan Hong,
Mathias Uhlén,
Thomas Renné,
Jochen M. Schwenk,
Göran Bergström,
Jacob Odeberg,
Lynn M. Butler
Publication year - 2021
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.121.316779
Subject(s) - biomarker , body mass index , medicine , risk factor , disease , diabetes mellitus , population , framingham risk score , obesity , framingham heart study , blood proteins , endothelial dysfunction , endocrinology , bioinformatics , biology , environmental health , biochemistry
Endothelial cell (EC) dysfunction is a well-established response to cardiovascular disease risk factors, such as smoking and obesity. Risk factor exposure can modify EC signaling and behavior, leading to arterial and venous disease development. Here, we aimed to identify biomarker panels for the assessment of EC dysfunction, which could be useful for risk stratification or to monitor treatment response. Approach and Results: We used affinity proteomics to identify EC proteins circulating in plasma that were associated with cardiovascular disease risk factor exposure. Two hundred sixteen proteins, which we previously predicted to be EC-enriched across vascular beds, were measured in plasma samples (N=1005) from the population-based SCAPIS (Swedish Cardiopulmonary Bioimage Study) pilot. Thirty-eight of these proteins were associated with body mass index, total cholesterol, low-density lipoprotein, smoking, hypertension, or diabetes. Sex-specific analysis revealed that associations predominantly observed in female- or male-only samples were most frequently with the risk factors body mass index, or total cholesterol and smoking, respectively. We show a relationship between individual cardiovascular disease risk, calculated with the Framingham risk score, and the corresponding biomarker profiles.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom